|
KMID : 1189120090060010001
|
|
대한의학유전학회지
2009 Volume.6 No. 1 p.1 ~ p.7
|
|
|
DNA Methylation changes in Human Cancers
|
|
Kwon Hyung-Joo
Kang Gyeong-Hoon
|
|
|
Abstract
|
|
|
Epigenetic changes represented by promoter CpG island hypermethylation and histone modification are an important carcinogenetic mechanism, which is found in virtually all histologic types of human cancer. About 60-70% of human genes harbor CpG islands in their promoters and 5’ exonal sequences, and some of them undergo aberrant promoter CpG island hypermethylation and subsequent downregulation of gene expression. The loss of expression in tumor suppressor or tumor-related genes results in acceleration of tumorigenic processes. In addition to regional CpG island hypermethylation,
diffuse genomic hypomethylation represents an important aspect of DNA methylation changes occurring in human cancer cells and contributes to chromosomal instability. These apparently contrasting methylation changes occur not only in human cancer cells, but also in premalignant cells. CpG island hypermethylation has gained attention for not only the tumorigenic mechanistic process, but also its potential utilization as a tumor biomarker. DNA methylation markers are actively investigated for their potential uses as tumor biomarkers for diagnosis of tumors in body fluids, prognostication of
cancer patients, or prediction of chemotherapeutic drug response. In this review, these aspects will be discussed in detail.
|
|
|
KEYWORD
|
|
|
Cancer, CpG island, DNA methylation, Tumor biomarker
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|